Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
AstraZeneca
Medtronic
Dow
McKesson

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for OTSUKA PHARMACEUTICAL CO., LTD. v. STASON INDUSTRIAL CORP. (D.N.J. 2016)

See Plans and Pricing

« Back to Dashboard

OTSUKA PHARMACEUTICAL CO., LTD. v. STASON INDUSTRIAL CORP. (D.N.J. 2016)

Docket   Start Trial Date Filed 2016-02-01
Court District Court, D. New Jersey Date Terminated
Cause 35:271 Patent Infringement Assigned To Jerome B. Simandle
Jury Demand None Referred To Karen M. Williams
Parties BRECKENRIDGE PHARMACEUTICAL, INC.; OTSUKA PHARMACEUTICAL CO., LTD.; STASON INDUSTRIAL CORP.; STASON PHARMACEUTICALS INC.; TAI HENG INDUSTRY CO., LTD.; ZHEJIANG JINHUA CONBA BIO-PHARM CO., LTD
Patents 9,089,567; 9,125,939
Attorneys MELISSA ANNE CHUDEREWICZ
Firms Pepper Hamilton LLP
Link to Docket External link to docket
Small Molecule Drugs cited in OTSUKA PHARMACEUTICAL CO., LTD. v. STASON INDUSTRIAL CORP.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for OTSUKA PHARMACEUTICAL CO., LTD. v. STASON INDUSTRIAL CORP. (D.N.J. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-02-01 1 infringement of U.S. Patent No. 9,089,567 (“the ’567 patent”), arising under the United States patent laws, Title… 17. The U.S. Patent and Trademark Office (“PTO”) issued the ’567 patent on July 28, 2015, entitled…’567 patent is attached as Exhibit A. 18. Otsuka is the owner of the ’567 patent by virtue…19. The ’567 patent expires on January 28, 2022, subject to any supplemental patent term adjustment… ) COMPLAINT FOR PATENT INFRINGEMENT Plaintiff Otsuka Pharmaceutical External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Merck
Mallinckrodt
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.